Chief executive Kim Dong-chun told a town hall meeting on Monday that the company would cultivate semiconductor, mobility and robotics materials, along with cancer drugs, as its core future businesses, sharpening a portfolio long anchored in commodity chemicals.
The strategy comes as global oversupply and intensifying competition erode margins across the traditional petrochemical industry, pushing producers toward faster-growing, higher-margin sectors.
LG Chem aims to reach a double-digit operating margin by 2030.
About 70 percent of the R&D budget will flow to the targeted growth businesses, with the company concentrating on AI-based applications and frontier technologies.
LG Chem said it had set up a new business-development unit reporting directly to the CEO in June and would pursue mergers and acquisitions to accelerate expansion.
In semiconductors, the company plans to deepen its advanced-packaging lineup and grow electronic-materials revenue to 2 trillion won by 2030, while extending its mobility reach into robot structural and precision-bonding materials.
It also intends to strengthen its cancer-drug pipeline through global trials, licensing and partnerships.
"LG Chem will leap forward into a technology-strong converting company," Kim said, vowing to focus capabilities on a growth axis centered on semiconductor, mobility and robotics materials and cancer drugs.
Copyright ⓒ Aju Press All rights reserved.